Allelic loss at PTEN locus leads to progression of colorectal carcinoma among North Indian patients

References

• Ahuja N, Mohan AL, Li Q, et al. (1997). Association between CpG island methylation and microsatellite instability in colorectal cancer. Cancer Res 57:3370–4.
   PubMed Web of Science ®Google Scholar
• Ali A, Saluja SS, Hajela K, et al. (2013). Mutational and expressional analysis of PTEN gene in colorectal cancer from Northern India. Mol Carcinogene 53:45–52.
   Web of Science ®Google Scholar
• Alyasiri NS, Ali A, Kazim Z, et al. (2013). Aberrant promoter methylation of PTEN gene among Indian patients with oral squamous cell carcinoma. Inst J Biol Marker 28:298–302.
   PubMed Web of Science ®Google Scholar
• Alyasiri NS, Mehdi SJ, Alam MS, et al. (2012). PTEN-mediated Akt activation contributes to the reduced apoptosis among Indian oral squamous cell carcinoma patients. J Cancer Res Clin Oncol 138:103–9.
   PubMed Web of Science ®Google Scholar
• Balesaria S, Brock C, Bower M, et al. (1999). Loss of chromosome 10 is an independent prognostic factor in high-grade gliomas. Br J Cancer 81:1371–7.
   PubMed Web of Science ®Google Scholar
• Bockmuhl U, Schluns K, Schmidt S, et al. (2002). Chromosomal alterations during metastasis formation of head and neck squamous cell carcinoma. Genes Chromosomes Cancer 33:29–35.
   PubMed Web of Science ®Google Scholar
• Bose S, Wang SI, Terry MB, et al. (1998). Allelic loss of chromosome 10q23 is associated with tumor progression in breast carcinomas. Oncogene 17:123–7.
   PubMed Web of Science ®Google Scholar
• Cacev T, Radosevic S, Spaventi R, et al. (2005). NF1 gene loss of heterozygosity and expression analysis in sporadic colon cancer. Gut 54:1129–35.
   PubMed Web of Science ®Google Scholar
• Cappellen D, Gil Diez de Medina S, Chopin D, et al. (1997). Frequent loss of heterozygosity on chromosome 10q in muscle-invasive transitional cell carcinomas of the bladder. Oncogene 14:3059–66.
   PubMed Web of Science ®Google Scholar
• Cheung TH, Lo KW, Yim SF, et al. (2004). Epigenetic and genetic alternation of PTEN in cervical neoplasm. Gynecol Oncol 93:621–7.
   PubMed Web of Science ®Google Scholar
• Dahia PL, Marsh DJ, Zheng Z, et al. (1997). Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors. Cancer Res 57:4710–13.
   PubMed Web of Science ®Google Scholar
• Ferlay J, Shin HR, Bray F, et al. (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893–917.
   PubMed Web of Science ®Google Scholar
• Hlobilkova A, Knillova J, Bartek J, et al. (2003). The mechanism of action of the tumour suppressor gene PTEN. Biomed Pap Med Fas Univ Palacky Olomouc Czech Repub 147:19–25.
   PubMedGoogle Scholar
• Jemal A, Siegel R, Xu J, Ward E. (2010). Cancer statistics, 2010. CA Cancer J Clin 60:277–300.
   PubMed Web of Science ®Google Scholar
• Karoui M, Tresallet C, Julie C, et al. (2004). Loss of heterozygosity on 10q and mutational status of PTEN and BMPR1A in colorectal primary tumours and metastases. Br J Cancer 90:1230–4.
   PubMed Web of Science ®Google Scholar
• Knudson AG. (1993). Antioncogenes and human cancer. Proc Natl Acad Sci USA 23:10914–21.
   Web of Science ®Google Scholar
• Komiya A, Suzuki H, Ueda T, et al. (1996). Allelic losses at loci on chromosome 10 are associated with metastasis and progression of human prostate cancer. Genes Chromosomes Cancer 17:245–53.
   PubMed Web of Science ®Google Scholar
• Li DM, Sun H. (1997). TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta. Cancer Res 57:2124–9.
   PubMed Web of Science ®Google Scholar
• Li J, Yen C, Liaw D. (1997). PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275:1943–7.
   PubMed Web of Science ®Google Scholar
• Li YL, Tian Z, Wu DY, et al. (2005). Loss of heterozygosity on 10q23.3 and mutation of tumor suppressor gene PTEN in gastric cancer and precancerous lesions. World J Gastroenterol 11:285–8.
   PubMed Web of Science ®Google Scholar
• Mao X, Hamoudi RA, Talbot IC, Baudis M. (2006). Allele-specific loss of heterozygosity in multiple colorectal adenomas: toward an integrated molecular cytogenetic map II. Cancer Genet Cytogenet 167:1–14.
   PubMedGoogle Scholar
• Mehdi SJ, Alam MS, Batra S, Rizvi MA. (2011). Allelic loss of 6q25-27, the PARKIN tumor suppressor gene locus, in cervical carcinoma. Med Oncol 28:1520–6.
   PubMed Web of Science ®Google Scholar
• O’Connell JB, Maggard MA, Ko CY. (2004). Colon cancer survival rates with the new American Joint Committee on Cancer Sixth Edition Staging. J Natl Cancer Inst 96:1420–5.
   PubMed Web of Science ®Google Scholar
• Petersen S, Wolf G, Bockmuhl U, et al. (1998). Allelic loss on chromosome 10q in human lung cancer: association with tumour progression and metastatic phenotype. Br J Cancer 77:270–26.
   PubMed Web of Science ®Google Scholar
• Preacher KJ. (2001). Calculation for the chi-square test: an interactive calculation tool for chi-square tests of goodness of fit and independence; [Computer software]. Available at: http://www.quantpsy.org.
   Google Scholar
• Rizvi MA, Alam MS, Mehdi SJ, et al. (2011a). Allelic loss of 10q23.3, the PTEN gene locus in cervical carcinoma from Northern Indian population. Pathol Oncol Res 18:309–13.
   PubMed Web of Science ®Google Scholar
• Rizvi MA, Alam MS, Ali A, et al. (2011b). Aberrant Promoter methylation and inactivation of PTEN gene in cervical carcinoma from Indian population. J Cancer Res Clin Oncol 137:1255–62.
   PubMed Web of Science ®Google Scholar
• Rizvi MA, Ali A, Mehdi SJ, et al. (2013). Association of epigenetic alteration in PTEN gene with colorectal cancer progression among Indian population. Int J Colorectal Dis 28:283–4.
   PubMed Web of Science ®Google Scholar
• Robins SL, Kumar V. (1987). Basic pathology. West Washington Square (PA): W.B. Sounders Company, 718–31.
   Google Scholar
• Sambrook J, Russell DW. (2001). Molecular cloning: a laboratory manual. 3rd ed. Plainview: Cold Spring Harbor Laboratory Press.
   Google Scholar
• Silva A, Yunes JA, Cardoso BA, et al. (2008). PTEN posttranslational inactivation and hyperactivation of the PI3K/Akt pathway sustain primary T cell leukemia viability. J Clin Invest 118:3762–74.
   PubMed Web of Science ®Google Scholar
• Steck PA, Pershouse MA, Jasser SA. (1997). Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 15:356–62.
   PubMed Web of Science ®Google Scholar
• Vogelstein B, Fearon ER, Kern SE, et al. (1989). Allelotype of colorectal carcinomas. Science 244:207–11.
   PubMed Web of Science ®Google Scholar
• Yamamoto S, Midorikawa Y, Morikawa T, et al. (2010). Identification of chromosomal aberrations of metastatic potential in colorectal carcinoma. Genes Chromosomes Cancer 49:487–96.
   PubMed Web of Science ®Google Scholar
• Yao YJ, Ping XL, Zhang H, et al. (1999). PTEN/MMAC1 mutations in hepatocellular carcinomas. Oncogene 18:3181–5.
   PubMed Web of Science ®Google Scholar
• Yokomizo A, Tindall DJ, Drabkin H, et al. (1998). PTEN/MMAC1 mutations identified in small cell, but not in non-small cell lung cancers. Oncogene 17:475–9.
   PubMed Web of Science ®Google Scholar
• Zaitsu Y, Oki E, Ando K, et al. (2015). Loss of heterozygosity of PTEN (encoding phosphate and tensin homolog) associated with elevated HER2 expression is an adverse prognostic indicator in gastric cancer. Oncology 88:189–94.
   PubMed Web of Science ®Google Scholar
• Zheng HT, Peng ZH, Zhou CZ, et al. (2005). Detailed deletion mapping of loss of heterozygosity on 22q13 in sporadic colorectal cancer. World J Gastroenterol 11:1668–72.
   PubMed Web of Science ®Google Scholar
• Zhou XP, Loukola A, Salovaara R, et al. (2002). PTEN mutational spectra, expression levels, and subcellular localization in microsatellite stable and unstable colorectal cancers. Am J Pathol 161:439–47.
   PubMed Web of Science ®Google Scholar